Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
955,598,456
-
Total 13F shares
-
319,440
-
Share change
-
-4,150
-
Total reported value
-
$4,808,013
-
Price per share
-
$15.05
-
Number of holders
-
22
-
Value change
-
-$2,054,856
-
Number of buys
-
10
-
Number of sells
-
12
Institutional Holders of KALA BIO, Inc. - Common Stock, $0.001 par value (KALA) as of Q1 2023
As of 31 Mar 2023,
KALA BIO, Inc. - Common Stock, $0.001 par value (KALA) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
319,440 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Inc., JANE STREET GROUP, LLC, Samsara BioCapital, LLC, Board of Trustees of The Leland Stanford Junior University, BANK OF AMERICA CORP /DE/, Knights of Columbus Asset Advisors LLC, and UBS Group AG.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.